AdvisorShares Psychedelics ETF Rating $19.35 -1.29 (-6.25%) Closing price 10/10/2025 04:10 PM EasternExtended Trading$18.93 -0.42 (-2.14%) As of 10/10/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.54Holdings in PSIL have an aggregate rating of Moderate Buy based on 117 analyst ratings issued in the past year covering 18 companies (80.9% of the portfolio).PSIL Aggregate Price Target$19.35High Prediction$19.35Average Prediction$19.35Low Prediction$19.35Holdings in PSIL have an aggregate price target of $19.35 and a range of $19.35 to $19.35 covering 18 companies (80.9% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell4 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 18 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.73%ATAIatai Life Sciences$5.10-6.4%3.1841 of 5 stars2.86$11.25 120.6%7Positive NewsAnalyst Forecast7.75%CMPSCOMPASS Pathways$6.22-3.4%2.9958 of 5 stars2.63$16.29 161.8%8News CoverageAnalyst Forecast7.19%MNMDMind Medicine (MindMed)$11.81-5.5%2.2897 of 5 stars2.88$26.50 124.4%8Analyst Forecast6.16%NRXPNRx Pharmaceuticals$3.17-11.0%3.096 of 5 stars2.71$34.50 988.3%7Analyst Forecast4.52%GHRSGH Research$12.59-4.5%2.9735 of 5 stars2.67$32.00 154.2%9News CoverageAnalyst Forecast4.48%VTGNVistaGen Therapeutics$4.03-4.3%1.0338 of 5 stars2.002News CoverageAnalyst Forecast4.46%RLMDRelmada Therapeutics$2.04-7.3%2.7086 of 5 stars1.75$1.00 -51.0%4News CoverageAnalyst Forecast4.45%NEUPNeuphoria Therapeutics$17.50-7.9%2.1555 of 5 stars2.33$28.00 60.0%3Analyst Downgrade4.40%SUPNSupernus Pharmaceuticals$49.00-1.0%4.0269 of 5 stars3.00$64.00 30.6%5Trending NewsAnalyst ForecastInsider Trade4.39%NBIXNeurocrine Biosciences$136.63-1.3%4.7719 of 5 stars2.80$163.44 19.6%20Analyst Forecast4.29%ALKSAlkermes$31.21-0.5%4.3514 of 5 stars2.93$42.00 34.6%143.83%JNJJohnson & Johnson$190.66-0.2%4.6674 of 5 stars2.73$192.94 1.2%22Trending NewsUpcoming EarningsAnalyst Forecast3.19%STIMNeuronetics$2.79-5.1%1.7856 of 5 stars2.00$7.00 150.9%2News CoverageAnalyst Forecast1.74%IXHLIncannex Healthcare$0.39-6.7%0.7175 of 5 stars1.001News CoverageAnalyst ForecastGap Up1.34%SILOSilo Pharma$0.56-14.5%1.0083 of 5 stars1.001Gap Up1.15%KTTAPasithea Therapeutics$0.75-5.1%1.0436 of 5 stars1.001Positive News0.76%ENVBEnveric Biosciences$0.63-11.3%2.0839 of 5 stars2.00$10.00 1,500.0%2Analyst Forecast0.11%PBMPsyence Biomedical$3.61-2.4%1.2853 of 5 stars1.001News CoverageAnalyst Forecast This page (NYSEARCA:PSIL) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
